Calithera Biosciences
(OTC) CALA
Calithera Biosciences Financials at a Glance
Market Cap
$1,500
Revenue (TTM)
$0.00
Net Income (TTM)
$20.36M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.78 (High)
Dividend
$0.00
Beta (Volatility)
1.78 (High)
Price
$0.00
Volume
1,262
Open
$0.00
Price
$0.00
Volume
1,262
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
1.78 (High)
Price
$0.00
Volume
1,262
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
CALA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Calithera Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
Susan M. Molineaux, PhD
Website
www.calithera.comHeadquarters
South San Francisco, CA 94080, US
CALA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-66%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.50K
Shares Outstanding
4.87M
Volume
1.26K
Short Interest
0.00%
Avg. Volume
126.344
Financials (TTM)
Gross Profit
$1.39M
Operating Income
$42.07M
EBITDA
$38.27M
Operating Cash Flow
$43.61M
Capital Expenditure
$133.00K
Free Cash Flow
$43.74M
Cash & ST Invst.
$25.45M
Total Debt
$1.67M
Calithera Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$357.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.50K
N/A
Market Cap/Employee
$187.50
N/A
Employees
8
N/A
Net Income
$6.94M
+94.2%
EBITDA
$7.28M
+60.1%
Quarterly Fundamentals
Net Cash
$23.79M
-57.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$136.00K
-91.8%
Short Term Debt
$1.53M
+11.4%
Return on Assets
-65.79%
N/A
Return on Invested Capital
-1.98%
N/A
Free Cash Flow
$8.62M
+66.3%
Operating Cash Flow
$8.60M
+66.4%